2SATOH M, NAKAMURA M, SAITOH H, et al. Aldosterone synthase(CYP11 B2) expression and myocardial fibrosis in the failing human heart[J].Clin Sci, 2002, 102 (4): 381-386.
5PITT B, REMME W. ZANNAD F. et al. Eplerenone, a selective aldosteone blocker, in patients with left ventricular dysfunction after myocardialin farction[J]. N Engl J Med, 2003, 348 (14): 1309-1321.
6ZANNAD F. DOUSSET B, ALLA, F. Treatment of congestive heart failure interfering the aldosterone cardiac extracellular matrix relationship [ J ]. Hypertension, 2001, 38 (5): 1227-1232.
7HIRSH J, FUSTER V, ANSELL J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy [J]. J Am Coil Cardiol, 2003, 41 (9) : 1633-1652.
8HAYASHI M. TSUTAMOTO T. WADA A. et al. Immediate administration of mineralocortieoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction [J]. Circulation, 2003. 107 (20): 2559-2565.
二级参考文献11
1Silvestre JS.Robert V,Heymes C.et al.Myocardial production of aldosterone and corticosterone in therat[J].J Biol Chem 1998, 273:4883-4891.
2Silvestre JS.Heymes C.Oubenaissa A.et al.Activation of cardiac aldosterone productioninratmyocardial infarction effect of angiotensin Ⅱ receptro blockade and role in cardiac fibrosis[J].Circulation 1999,99:2694-2701.
3Lombes M.Alfaidy N.Eugene E.et al.Prerequisite forcardiac.aldosterone action mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart[J].Circulation 1995, 92: 175-182.
4Robert V.Heymes C.Silvestre JS.et al.Angiotensin ATI receptor subtype as a cardiac target of aldosterone.role in aldosterone-salt-induced fibrosis[J],Hypertension 1999,33:981-986.
8Kawano H.Do YS.Kawano Y.et al.Angiotensin Ⅱ hasmultiple profibrotic effects in human cardiac fibroblasts[J].Circulation 2000,101 : 1130-1137.
9van Kats JP.Duncker DJ.Haitsma.DB.et al.Angiotensin-converting enzyme inhibition and angiotensin Ⅱ type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction role of tissue angiotensinⅡ[J].Circulation 2000,102:1556-1563.
10McKelvie RS.Yusuf.S.Pericak .D et al.Comparison ofcandesartan.enalapril.and theri combination in congestive heart failure randomized evaluation of strategies for left ventricular dysfunction(RESOLVD)pilot study.the RESOLVD pilot study investignators[J]. Circularly,1999,100:1056-1064.
8RITZ E,KOLEGANOVA N.Aldosterone in uremia-beyond blood pressure[J].Blood Purif,2010,29 (2):111-113.
9GIACCHETTI G,RONCONI V,LUCARELLI G,et al.Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism:need for a standardized protocol[J].J Hypertens,2006,24 (4):737-745.
10MULATERO P,STOWASSER M,LOH K C,et al.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents[J].J Clin Endocrinol Metab,2004,89 (3):1045-1050.
